Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90. [2]高晓虹, 安庆玉, 李晓枫. 大肠癌相关因素的条件logistic回归分析[J]. 中国卫生统计, 2009, 26(6): 605-607. [3]Vander-Heiden M G. Targeting cancer metabolism: a therapeutic window opens[J]. Nat Rev Drug Discov, 2011, 10(9): 671-684. [4]Jacobs R J, Voorneveld P W, Kodach L L, et al. Cholesterol metabolism and colorectal cancers[J]. Curr Opin Pharmacol, 2012, 12(6): 0-695. [5]Luu W, Zerenturk E J, Kristiana I, et al. Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis[J]. J Lipid Res, 2014, 55(3): 410-420. [6]Wu C, Miloslavskaya I, Demontis S, et al. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1[J]. Nature, 2004, 432(7017): 640-645. [7]Doherty S C, McKeown S R, Lopez J A, et al. Gene expression in normal urothelium depends on location within the bladder: a possible link to bladder carcinogenesis[J]. Eur Urol, 2006, 50(2): 290-301. [8]Sarkar D, Imai T, Kambe F, et al. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas[J]. J Clin Endocrinol Metab, 2001, 86(11): 5130- 5137. [9]Luciani P, Gelmini S, Ferrante E, et al. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas[J]. J Clin Endocrinol Metab, 2005, 90(11): 6156-6161. [10]Bonaccorsi L, Luciani P, Nesi G, et al. Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer[J]. Lab Invest, 2008, 88(10): 1049-1056. [11]Di-Stasi D, Vallacchi V, Campi V, et al. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis[J]. Int J Cancer, 2005, 115(2): 224-230. [12]Yen H K, Fauzi A R, Din L B, et al. Involvement of Seladin-1 in goniothalamin-induced apoptosis in urinary bladder cancer cells[J]. BMC Complement Altern Med, 2014, 14: 295. [13]Lee G T, Ha Y S, Jung Y S, et al. DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells[J]. Ann Surg Oncol, 2014, 21(Suppl 4): S538-S545. [14]Jarvinen R, Knekt P, Hakulinen T, et al. Dietary fat, cholesterol and colorectal cancer in a prospective study[J]. Br J Cancer, 2001, 85(3): 357-361. [15]Yao X, Tian Z. Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies[J]. Cancer Causes Control, 2015, 26(2): 257-268. [16]Esteve E, Ricart W, Fernandez-Real J M. Dyslipidemia and inflammation: an evolutionary conserved mechanism[J]. Clin Nutr, 2005, 24(1): 16- 31. [17]Al-Haidari A A, Syk I, Thorlacius H. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration ？via？ geranylgeranylation and RhoA activation[J]. Biochem Biophys Res Commun, 2014, 446(1): 68-72. [18]Lasuncion M A, Martin-Sanchez C, Canfran-Duque A, et al. Post-lanosterol biosynthesis of cholesterol and cancer[J]. Curr Opin Pharmacol, 2012, 12(6): 717- 723. [19]Selkoe D J. Alzheimer's disease: genes, proteins, and therapy[J]. Physiol Rev, 2001, 81(2): 741-766. [20]Salem N E, Saito M, Kasama Y, et al. Genomic polymorphisms in 3beta-hydroxysterol Delta24-reductase promoter sequences[J]. Microbiol Immunol, 2013, 57(3): 179-184. [21]Khuda I I, Koide N, Noman A S, et al. Seladin-1 is a novel lipopolysaccharide (LPS)-responsive gene and inhibits the tumour necrosis factor-alpha production and osteoclast formation in response to LPS[J]. Immunology, 2010, 131(1): 59-66.
[2]
刘晓丽,马礼鸿,王全义,等.XIAP、c-jun在肺癌组织中的表达及其意义[J].第三军医大学学报,2012,34(23):2408. Liu Xiaoli,Ma Lihong,Wang Quanyi,et al.Expression and clinical significance of XIAP and c-jun in human lung cancer tissues[J].J Third Mil Med Univ,2012,34(11):2408. [2]蒋平,关伟,戴楠,等.DNA损伤修复基因以及TS、β-tubulinⅢ在骨肉瘤中的表达及其与临床病理的关系[J].第三军医大学学报,2013,35(01):61. Jiang Ping,Guan Wei,Dai Nan,et al.Expression of DNA damage repair genes, thymidylate synthase and β-tubulin Ⅲ in human osteosarcoma tissues and its relationship with clinical pathology of osteosarcoma[J].J Third Mil Med Univ,2013,35(11):61. [3]杨兆瑞,吴晴,陈嘉薇,等.HIF-1α、JNK1、P-gp、MRP1和LRP蛋白在胃癌中的表达与临床病理及预后的关系[J].第三军医大学学报,2007,29(18):1755. YANG Zhao-rui,WU Qing,CHEN Jia-wei,et al.Expressions, clinicopathological features and prognostic significance of HIF-1α, JNK1, P-gp, MRP1 and LRP proteins in human gastric carcinoma[J].J Third Mil Med Univ,2007,29(11):1755. [4]吴晋蓉,曾发贵,王清良,等.定量分析人脑星形细胞肿瘤组织芯片中血管生成与肿瘤微血管结构[J].第三军医大学学报,2006,28(10):1090. [5]王清良,卞修武,章容,等.人脑星形细胞肿瘤微血管组织芯片的构建[J].第三军医大学学报,2006,28(09):886. [6]唐春兰,杨和平,卞修武,等.应用组织芯片技术研究非小细胞肺癌中MMP-2、MMP-9的表达及临床病理意义[J].第三军医大学学报,2009,31(06):518. TANG Chun-lan,YANG He-ping,BIAN Xiu-wu,et al.Clinicopathological significance of MMP-2 and MMP-9 expressions in non-small cell lung cancer: a tissue microarray study[J].J Third Mil Med Univ,2009,31(11):518. [7]许颖,吴东明,石娇,等.上皮膜蛋白2多肽疫苗在鼠乳腺癌中的免疫防治效果研究[J].第三军医大学学报,2015,37(23):2338. Xu Ying,Wu Dongming,Shi Jiao,et al.Epithelial membrane protein 2 peptide vaccine in immunological control of breast carcinoma in mice[J].J Third Mil Med Univ,2015,37(11):2338. [8]张真真,张声,余英豪,等.Claudin-3在胃腺癌的表达及预后意义[J].第三军医大学学报,2011,33(12):1250. Zhang Zhenzhen,Zhang Sheng,Yu Yinghao,et al.Expression of Claudin-3 in gastric adenocarcinoma tissue and its relation with prognosis[J].J Third Mil Med Univ,2011,33(11):1250. [9]邓佳,谢赣丰,舒秋霞,等.脂肪酰胺水解酶在结直肠癌中的表达及临床意义[J].第三军医大学学报,2012,34(09):899. Deng Jia,Xie Ganfeng,Shu Qiuxia,et al.Expression of fatty acid amide hydrolase in colorectal cancer and its clinical significance[J].J Third Mil Med Univ,2012,34(11):899. [10]肖瑜,龙驰,张明慧,等.Beclin-1在非小细胞肺癌中的表达与意义[J].第三军医大学学报,2013,35(12):1271. Xiao Yu,Long Chi,Zhang Minghui,et al.Expression of Beclin-1 in non-small cell lung cancer and its clinical significance[J].J Third Mil Med Univ,2013,35(11):1271.
